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IL-21 Limits NK Cell Responses and Promotes
Antigen-Specific T Cell Activation: A Mediator
of the Transition from Innate to Adaptive Immunity
sponse remain to be defined. The concordance of de-
creased NK cell responses with the emergence of anti-
gen-specific T cells makes it likely that T cell-derived
factors influence the final steps of NK cell maturation.
IL-21 is a newly described cytokine produced by acti-
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T cell proliferation, potentiation of NK cell maturationMary Collins,1 Deborah A. Young,1,3
and Michael J. Grusby 2 from bone marrow progenitors, and activation of periph-
eral NK cells in human assay systems (Parrish-Novak1Genetics Institute
Wyeth Research et al., 2000). The cytokine itself is related to IL-2, IL-4,
and IL-15, and cellular effects are mediated through aCambridge, Massachusetts 02140
2 Department of Immunology and Infectious Disease class I cytokine family receptor, IL-21R (Parrish-Novak
et al., 2000; Ozaki et al., 2000). IL-21R has homology toHarvard School of Public Health
Boston, Massachusetts 02115 the shared  chain of the IL-2 and IL-15 receptors (Ozaki
et al., 2000), interacts with the common  cytokine re-
ceptor chain (c) (Asao et al., 2001), and appears to
signal by association with Jak1 (Ozaki et al., 2000; AsaoSummary
et al., 2001) and Jak3 (Asao et al., 2001), and phosphory-
lation of STAT1 and STAT3 (Asao et al., 2001) or STAT5IFN/, IL-12, and IL-15 regulate NK cell activation
and expansion, but signals triggering resolution of the (Ozaki et al., 2000). Although signaling chains other than
c have not been detected, the many functions of IL-21NK response upon induction of adaptive immunity re-
main to be defined. We now report that IL-21, a product so far described, the widespread lymphoid distribution
of its receptor (Parrish-Novak et al., 2000), and indica-of activated T cells, may serve this function. Mice lack-
ing IL-21R (IL-21R/) had normal NK cell development tions that coexpression of IL-21R and c, while neces-
sary, may not be sufficient to mediate signaling in all cellbut no detectable responses to IL-21. IL-21 enhanced
cytotoxic activity and IFN production by activated types (Ozaki et al., 2000) raise the potential for additional
receptor forms.murine NK cells but did not support their viability, thus
limiting their duration of activation. Furthermore, IL-21 To explore the role of IL-21 in regulating innate and
adaptive immunity, two complementary approachesblocked IL-15-induced expansion of resting NK cells,
thus preventing the initiation of further innate re- were employed. In vitro studies examined effects of IL-
21 on NK and T lymphocyte growth and function, alonesponses. In contrast, IL-21 enhanced the proliferation,
IFN production, and cytotoxic function of CD8 ef- and in conjunction with IL-15. Reciprocal studies done
with mice lacking functional IL-21R (IL-21R/) ad-fector T cells in an allogeneic MLR. These observa-
tions suggest that IL-21 promotes the transition be- dressed the influence of a lack of IL-21 signaling on
innate and adaptive immunity. IL-21R/ mice had nor-tween innate and adaptive immunity.
mal lymphocyte compartments and no NK cell defi-
ciency, an unexpected finding given the previouslyIntroduction
described role of IL-21 in human NK cell maturation
(Parrish-Novak et al., 2000). Cells from these mice didInnate immune mechanisms shape the adaptive cellular
responses that follow. In turn, adaptive immunity likely not display any response to IL-21 detectable in these
assays, including effects on T cell proliferation, NK cellfeeds back to limit ongoing innate responses, but the
mechanisms by which this occurs are poorly under- activation and expansion, and cytokine receptor expres-
sion. Our findings in the mouse reveal that innate NKstood. During acute pathogen infections, the NK cell
response begins within hours, as IFN/, IL-12, IL-15, cell responses and the cytokine-driven TCR-indepen-
dent outgrowth of CD44hi CD8T cells were antagonizedand IL-18 generated by infected cells stimulate NK cyto-
toxicity, cytokine production, and expansion (Biron et by IL-21, whereas antigen-driven T cell activation in an
allogeneic MLR was stimulated. As a product of acti-al., 1999). Along with enhanced effector function, the
maturation of NK cells is ultimately accompanied by vated T lymphocytes that acts to limit ongoing NK cell
expansion while promoting antigen-specific T cell-medi-their terminal differentiation. An emerging view (Loza
and Perussia, 2001) supports a sequential process of ated immunity, IL-21 may be a key element in the transi-
tion between innate and adaptive immune responses.NK cell development in the human system resulting in
generation of committed IFN-producing effector NK
cells whose subsequent terminal differentiation coin- Results
cides with abatement of the innate response. Although
cytokine regulation of initial NK cell recruitment and Generation and Characterization of IL-21R/ Mice
activation has been intensively studied (Biron et al., Mice were made genetically deficient in IL-21R (IL-
1999), the signals responsible for resolution of this re- 21R/) as described in Experimental Procedures and
outlined in Figure 1A. IL-21R/ mice were viable and
fertile and were bred on both BALB/c  C57BL/63 Correspondence: dyoung@wyeth.com
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Figure 1. Functional Inactivation of the IL-
21R Gene
(A) The structure of the wild-type allele, re-
combinant gene, and knockout construct are
shown at top, middle, and bottom, respec-
tively. The knockout construct, consisting of
a neomycin resistance cassette flanked by
appropriate linkers for homologous recombi-
nation, was targeted to replace the IL-21R
exon 1 sequence.
(B and C) Thymocytes isolated from (B) wild-
type (4611 and 4613) or IL-21R/ (4615 and
4616) mice or (C) lymph node cells pooled
from wild-type or IL-21R/ mice were incu-
bated 3 days with media (no cytokine), IL-21
(30 U/ml), or COS mock control on anti-CD3-
coated plates, and [3H]thymidine incorpora-
tion was assayed over the final 5 hr.
and C57BL/6 backgrounds. Adult IL-21R/ mice had affected the generation of mature NK cells, these cells
were quantitated in spleens of IL-21R/ mice. Resultsnormal numbers of peripheral blood erythrocytes,
monocytes, granulocytes, and lymphocytes (data not with mice on BALB/c  C57BL/6 and C57BL/6 back-
grounds were indistinguishable. Both the percentagesshown). Phenotypic analysis of T cell, B cell, and mono-
cyte populations in spleen, lymph node, and thymus (Figure 2A) and the total numbers of NK cells (3.06 
0.78  106/spleen for wild-type and 3.77  0.91  106/showed no significant differences between IL-21R/
and wild-type (data not shown). In the serum, IL-21R/ spleen for IL-21R/ mice) were equivalent, indicating
that IL-21R/ mice had no intrinsic defect in the genera-mice were found to have approximately 3-fold lower
levels of IgG1 (p  0.05), 2-fold lower levels of IgG2b tion of phenotypically mature NK cells.
Having established that IL-21R/ mice have a full(p  0.05), and 3-fold higher levels of IgE (p  0.02) as
compared to wild-type mice (data not shown). complement of spleen NK cells, we next examined the
ability of these cells to undergo activation in vivo andBecause reagents are not currently available for de-
tecting cell surface expression of murine IL-21R by phe- in vitro. All functional studies were done with mice on
the C57BL/6 background, unless otherwise noted. NKnotypic analysis, the absence of functional receptor was
confirmed by lack of IL-21 responsiveness in cells iso- cells from IL-21R/ mice were fully able to respond to
poly I:C in vivo (Figure 2B) or IL-15 in vitro (Figure 2C)lated from IL-21R/mice. In accordance with the obser-
vations of Parrish-Novak et al. (2000), IL-21 enhanced with induction of lytic activity that was indistinguishable
from that found in NK cells from wild-type animals. Thisthe proliferation of thymocytes from wild-type but not
IL-21R/ mice in response to suboptimal concentra- indicates that NK cells from IL-21R/ mice are fully
responsive to typical activating agents in vivo and intions of anti-CD3 (Figure 1B). In addition, IL-21 was
found to enhance anti-CD3-responsiveness of lymph vitro.
node T cells from wild-type but not IL-21R/ mice (Fig-
ure 1C). These observations support the functional inac-
IL-21 Reduces IL-15-Mediated Expansion but Hastivation of the IL-21R gene in IL-21R/ mice.
No Effect on Activation of Resting NK Cells
In addition to enhancing effector function, IL-15 en-
hances NK cell survival and proliferation (Carson et al.,IL-21R/ Mice Have Normal NK Cell Numbers
and Display Full NK Activation In Vivo 1997), and these effects were comparable using splenic
NK cells of wild-type and IL-21R/ mice (Figure 3A).and In Vitro
Parrish-Novak et al. (2000) observed that IL-21 en- IL-21 alone did not support expansion of NK cells in
vitro (data not shown). Therefore, to study the effectshanced the generation of NK cells from human bone
marrow progenitors. To determine if a lack of IL-21R of IL-21 on NK cell outgrowth, IL-21 was used in conjunc-
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Figure 2. IL-21R/ Mice Have Normal NK
Cell Number and Display Full NK Cell Activa-
tion In Vivo and In Vitro
(A) Flow cytometric analysis of spleen lym-
phocytes from wild-type or IL-21R/ mice.
NK cells, identified as NK1.1/CD3, are
boxed.
(B) Wild-type or IL-21R/ mice were injected
i.p. with poly I:C or PBS control, and spleens
were harvested 1.5 days later.
(C) Spleen cells isolated from wild-type or IL-
21R/ mice were treated in vitro with IL-15
(50 ng/ml) for 7 days, then used as effectors
in a 5 hr 51-Cr release assay against YAC-1
targets. Cells were pooled from 2–3 mice per
group.
tion with IL-15. For wild-type but not IL-21R/ cells, appeared contradictory, as no activation of murine
splenic NK cells was seen in response to IL-21 (Figureaddition of IL-21 inhibited IL-15-mediated NK cell
expansion in a 7-day culture (Figures 3A and 3B) but 4A). In an attempt to reconcile these observations, we
reasoned that human NK cells, continuously challengedhad no effect on total T cell numbers, which dropped
30% in these cytokine-driven, antigen-independent with environmental agents, may exist in a heightened
state of activation as compared to NK cells of a mousecultures (Figure 3A). Similar findings were seen with IL-
2-expanded cultures (data not shown). Kinetic analysis residing in a specific pathogen-free facility. Therefore,
IL-21 effects were examined on NK cells from mice thatrevealed that IL-21 blocked IL-15-mediated NK cell pro-
liferation throughout the culture period (Figure 3C). had been challenged in vivo with poly I:C to induce their
activation. Cells harvested from mice treated with polyRather than shifting the effective dose of IL-15 required
for NK cell expansion, IL-21 blocked NK cell outgrowth I:C or PBS control were restimulated for 2–3 days in vitro
with IL-15, IL-21, or COS mock control, then assayed forover the entire range of IL-15 concentrations to which
the NK cells responded (Figure 3D). Thus, IL-21 limits lytic activity. In contrast to its effects on NK cells from
resting mice, IL-21 alone induced a high level of cyto-outgrowth of NK cells in response to IL-15.
To further examine IL-21 effects on NK cell activation, toxic activity in NK cells from poly I:C-treated mice (Fig-
ure 4B). In order to determine whether heightened IL-freshly isolated murine splenocytes were cultured for
2–3 days in the presence of IL-21 and/or IL-15 and tested 21 responsiveness would also follow NK cell activation
in vitro, splenocytes were cultured for 7 days with IL-for cytotoxicity against NK-sensitive YAC-1 target cells.
In response to IL-15, resting NK cells from both wild- 15, then restimulated for 2 days with IL-21, IL-15, or the
combination. In this case, restimulation with either IL-21type and IL-21R/ mice became actively cytolytic (Fig-
ures 2C, 4A, and 4D). In contrast, IL-21 did not promote or IL-15 alone greatly enhanced NK cytotolytic function
(Figure 4C). Results shown in Figures 4B and 4C andactivation of resting NK cells (Figures 4A and 4D) and
had no effect on cytolytic potential per cell induced by other experiments (data not shown) suggest an additive
effect of IL-15 and IL-21 on NK cell activation, with noIL-15 (Figure 4A), although absolute NK cell numbers
were greatly reduced in cultures containing IL-15  IL- indication of synergy. Cells from IL-21R/ mice dis-
played full cytolytic activation with IL-15 but did not21 (Figure 3A). Taken together, these results indicate
that IL-21 antagonizes IL-15-induced growth but not respond to IL-21 (Figures 4D–4F). For these cells, IL-
15  IL-21 produced no greater activation than IL-15activation of resting NK cells.
alone (Figure 4F).
In addition to mediating cytotoxicity, activated NKIL-21 Enhances Cytotoxicity of Previously Activated
NK Cells and Induces Their Apoptosis cells produce IFN in an IL-12-dependent manner. In
order to determine whether IL-21 treatment of activatedParrish-Novak et al. (2000) found that IL-21 stimulates
cytotoxicity of human NK cells enriched by positive se- NK cells affected IFN production, spleen cells stimu-
lated in vitro for 7 days with IL-15 were rechallenged forlection from peripheral blood. Our results in the mouse
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Figure 3. IL-21 Prevents IL-15-Induced
Expansion of Resting NK Cells
Spleen cells from wild-type or IL-21R/ mice
were cultured for 7 days with IL-15 (10 ng/
ml)COS mock control or IL-15 IL-21 (12.5
U/ml).
(A) NK and T cell subsets were identified as
NK1.1/CD3 or NK1.1/CD3, respectively,
by flow cytometry. Results shown are aver-
ages of 5–11 experiments, each done with
lymphocytes pooled from 2–3 spleens (wild-
type, day 0 and treated, and IL-21R/, day
0) or with a single pool of 2–3 spleens (IL-
21R/ treated).
(B) Typical flow cytometric analysis of cells
from wild-type mice on day 7 of culture with
IL-15  COS mock control or IL-15  IL-21.
NK cells (NK1.1/CD3) are boxed.
(C) Spleen cells were cultured with IL-15 (10
ng/ml) in the presence of 6.25 U/ml IL-21 ()
or an equivalent volume of COS mock control
(). At the time points indicated, the percent-
age of NK cells (NK1.1/CD3) was deter-
mined by flow cytometry.
(D) Spleen cells were cultured with the indi-
cated concentration of IL-15 in the presence
of 6.25 U/ml IL-21 () or an equivalent volume
of COS mock control (). On day 7, the per-
centage of NK cells (NK1.1/CD3) was de-
termined by flow cytometry.
2 days with IL-15 and/or IL-21. Treatment of activated addition to boosting IL-12-dependent IFN production,
IL-21 treatment also resulted in high levels of IFN pro-NK cells with IL-21 greatly enhanced IL-12-driven IFN
production, and the response was further potentiated duction in the absence of added IL-12 (Figure 5A). In
contrast, when cells from IL-21R/ mice were activatedby the combination of IL-15 and IL-21 (Figure 5A). In
Figure 4. IL-21 Boosts NK Cytotoxicity in
Spleen Cells Activated with Poly I:C In Vivo
or IL-15 In Vitro but Does Not Induce Activa-
tion of Resting NK Cells
Resting cells: spleen cells isolated from wild-
type (A) or IL-21R/ (D) mice were treated
for 2–3 days with IL-15 (10 ng/ml)  COS
mock control (), COS mock control only (),
IL-21 (12.5 U/ml) only (), or (A) IL-15  IL-
21 (H17009). Poly I:C-activated cells: spleen cells
isolated from wild-type (B) or IL-21R/ (E)
mice 1.5 days post i.p. administration of poly
I:C were cultured 2 days with the indicated
treatment. IL-15-activated cells: spleen cells
isolated from untreated wild-type (C) or IL-
21R/ (F) mice were cultured 7 days with IL-
15 (10 ng/ml), then washed and restimulated
for 2 days with the treatments as described
above. Data are shown as meanSD of repli-
cate wells in a 5 hr 51-Cr release assay
against YAC-1 targets. Effector:target ratios
were corrected for the percentage of NK1.1/
CD3 cells in each culture, identified by flow
cytometry.
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Figure 5. IL-21 Boosts IFN Production by
IL-15-Activated Spleen Cells but Blocks Their
Growth
(A and B) Spleen cells isolated from wild-type
(A) or IL-21R/ (B) mice were cultured 7 days
with IL-15 (10 ng/ml), then restimulated for 2
days with IL-15 (10 ng/ml)  COS mock con-
trol (), COS mock control only (), IL-15 (10
ng/ml)  IL-21 (12.5 U/ml) (H17009), or IL-21 (12.5
U/ml) only (). For determination of IFN pro-
duction, cells were washed free of cytokine
and challenged for 24 hr with the indicated
concentration of murine IL-12. Data are
shown as mean  SD of IFN levels in repli-
cate culture wells.
(C) Cell concentrations from cultures acti-
vated 7 days with IL-15 and restimulated 2
or 5 days with the indicated treatment at the
doses indicated above. The NK cell concen-
tration on day 7 of culture with IL-15 (prior to
restimulation) was 4.1  106/ml.
(D) Apoptosis in spleen cell cultures ex-
panded for 5 days with IL-15 (10 ng/ml) and
restimulated for 1 or 2 days with agents as
described above. At each time point, cells
were stained for surface expression of NK1.1
and CD3 and intracellular TUNEL. Data are
shown for NK cells gated as NK1.1/CD3.
with IL-15, then challenged with IL-21, no enhanced 2 days of restimulation with IL-21 the majority of NK
cells in the culture were apoptotic (Figure 5D). Takenspontaneous or IL-12-driven IFN production was found
(Figure 5B). together with observations that cells in similarly treated
cultures restimulated for 2 days with IL-21 displayedThus, previously stimulated but not resting NK cells
showed strong induction of cytotolytic activity (Figures high levels of cytotolytic activity (Figure 4C) and IFN
production (Figure 5A), these findings indicate that IL-4A–4C) and IFN production (Figure 5A) when exposed
to IL-21. Experiments using FACS-sorted populations 21 induces high levels of effector function in NK cells
undergoing apoptosis. Restimulation with IL-15  IL-of	95% pure NK and T cells confirmed that both activi-
ties could be attributed almost exclusively to NK cells in 21 also resulted in enhanced NK cell effector function
(Figures 4C and 5A) but prevented or delayed apoptosisthese cultures (data not shown). Interestingly, however,
enhanced effector responses were not accompanied by (Figure 5D). This indicates that apoptosis is not a neces-
sary correlate of the IL-21-mediated enhancement ofgrowth effects. Cultures of IL-15-stimulated NK cells
that were rechallenged for 2 days with IL-21 contained NK cell effector function.
fewer NK cells than those maintained in IL-15 (Figure
5C). Examination of these cultures after 5 days of chal-
lenge confirmed that IL-21 not only failed to sustain NK IL-21 Blocks IL-15-Dependent Expansion of CD44hi
CD8 TCR-Independent T Cells and T Cellviability but, when used in combination with IL-15, IL-
21 reduced NK cell survival mediated by that cytokine Cytokine Receptor Expression
In the mouse, IL-15 in the absence of a TCR signal(Figure 5C). Thus, IL-21 boosted the effector functions
of activated NK cells but did not promote their viability, induces proliferation of CD8 T cells expressing high
levels of CD44, corresponding to a “memory” phenotypesuch that although activity per cell was increased, their
number was sharply reduced. (Zhang et al., 1998; Sprent and Surh, 2001). In accor-
dance with this, IL-15-expanded spleen CD8 T cellsBecause of its effects on viability, we examined the
influence of IL-21 on NK cell death by apoptosis trig- from either wild-type or IL-21R/ mice were skewed
toward high-level expression of CD44 (Figure 6A). Addi-gered by removal of IL-15. The TUNEL staining method
was used on IL-15-expanded cultures restimulated for tion of IL-21 counteracted the expansion of CD44hi CD8
T cells from wild-type mice but had no effect on cells2 days with IL-15, IL-21, or COS mock control superna-
tant. In cultures treated with COS mock control, most from IL-21R/ mice (Figure 6A). Because TCR-indepen-
dent CD44hi CD8 T cells are responsive to IFN in addi-NK cells were apoptotic within 1 day, indicating that
apoptosis occurs rapidly upon withdrawal of IL-15. As tion to IL-15 (Tough et al., 2001), expression of the IFN
receptor, CD119, was also examined. IL-21 also pre-compared to COS mock control, IL-21 delayed the apo-
ptosis caused by removal of IL-15. Nevertheless, after vented the expansion of cells expressing this marker in
Immunity
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Figure 6. IL-21 Prevents IL-15-Induced Expansion of CD44hi CD8 T Cells
Spleen cells isolated from IL-21R/ or wild-type mice (BALB/c  C57BL/6 background) were cultured 7 days in IL-15 (50 ng/ml)  COS mock
supernatant or IL-15  IL-21 (25 U/ml).
(A) Cell surface marker expression was analyzed on day 0 and on day 7 of culture. CD44, CD119, and CD132 were analyzed on gated CD8
CD3 cells. CD122 and CD25 were analyzed on total CD3 cells. Appropriate gates were established using three-color flow cytometry.
(B) Spleen cells grown 7 days with IL-15  COS mock supernatant or IL-15  IL-21 were washed free of cytokine, then replated with the
indicated concentration of IL-2 or IL-15. [3H]thymidine incorporation was assayed over 24 hr.
response to IL-15 on cells from wild-type but not IL- be reduced. In accordance with this, wild-type spleen
cells that had been expanded with IL-15 in the presence21R/ mice (Figure 6A).
To further examine IL-21 effects on the cytokine re- of IL-21 showed less proliferation in response to IL-2 or
IL-15 than those maintained in the absence of IL-21.sponsiveness of T cells expanded with IL-15, we exam-
ined CD25 (IL-2R ), CD122 (shared  chain of IL-2R Cells from IL-21R/ mice were unaffected by IL-21 (Fig-
ure 6B). Thus, IL-21 prevented IL-15-driven, antigen-and IL-15R), and CD132 (c) levels on spleen T cells
following exposure to IL-15 in the presence or absence independent T cell responses, including the expansion
of CD44hi CD8 cells and the increased expression ofof IL-21. Both CD25 and CD122 expression was in-
creased upon IL-15 treatment of cells from wild-type functional cytokine receptors.
and IL-21R/ mice. Addition of IL-21 prevented this
receptor induction on T cells from wild-type mice but IL-21 Enhances T Cell Responses to Alloantigen
Having shown that IL-21 blocks the cytokine-drivenhad no effect on cells from IL-21R/ mice (Figure 6A).
Expression of c (CD132) was not affected by IL-21 expansion of NK cells and of antigen-independent
CD44hi CD8 T cells, we asked whether IL-21 would(Figure 6A). The decreased expression of receptor
chains suggested that in the presence of IL-21 the re- have similar effects in an antigen-driven T cell response,
using a mixed lymphocyte reaction system. Purifiedsponsiveness of splenic T cells to IL-2 or IL-15 would
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IL-2, IL-15, or IL-12 (data not shown), but was not effec-
tive with IL-21R/ cells. Therefore, IL-15 or IL-2 was
added to generate sufficient numbers of cells to perform
these assays. T cells from wild-type or IL-21R/ mice
primed with alloantigen and IL-15 displayed strong CTL
activity toward allospecific target cells (Figure 7B). Prim-
ing in the presence of IL-15  IL-21 further enhanced
the development of lytic activity in wild-type but not IL-
21R/ cultures, indicating that IL-15 and IL-21 coopera-
tively enhance CTL differentiation. Similar results were
observed when cells were primed in the presence of IL-2
(data not shown). After priming with allogeneic APCs and
the indicated cytokines, wild-type or IL-21R/ T cells
were restimulated, and IFN production was determined
as another measure of effector function. Wild-type
T cells primed in the presence of IL-21, alone or in combi-
nation with IL-2 or IL-15, secreted higher titers of IFN
compared to those primed with IL-2 or IL-15 alone (Fig-
ure 7C). Taken together, these results suggest that IL-
21 enhances in vitro T cell responses to alloantigen in
primary stimulation and results in the generation of more
potent effector T cells.
Discussion
In this study, we have defined a role for IL-21 in the
maturation and activation of NK and T cell responses.
IL-21 was found to inhibit the IL-15-dependent expan-
sion of both resting NK cells and those that had under-
gone prior stimulation. On previously activated NK cells,
IL-21 failed to sustain viability but triggered a burst of
cytotoxicity and IFN production. IL-21 also blocked
the IL-15-driven, TCR-independent expansion of CD44hi
CD8 cells. In contrast, IL-21 enhanced proliferation,Figure 7. IL-21 Enhances T Cell Proliferation and Activation in Re-
cytotoxic activation, and IFN production by antigen-sponse to Alloantigen
specific T cells. None of these effects were seen in IL-(A) T cell enriched populations from lymph nodes of wild-type and
IL-21R/ mice (BALB/c  C57BL/6 background) were cultured 3–4 21R/ mice, confirming the requirement for this recep-
days with irradiated allogeneic spleen cells in the presence of no tor chain in mediating cellular responses to IL-21.
cytokine, IL-21 (10 U/ml), or COS mock control. [3H]thymidine incor- IL-21R/ mice had normal numbers of mature periph-
poration was assayed over the final 12 hr of culture.
eral NK cells, capable of full activation. This result is(B) Cells isolated from cultures of primary allogeneic stimulation
surprising in view of findings by Parrish-Novak et al.were assayed for cytotoxicity against allogeneic target cells in a 4
(2000) that IL-21 potentiates IL-15- and Flt3L-inducedhr 51-Cr release assay. Data are corrected for percentage of CD8
T cells under each priming condition. NK cell expansion from progenitors in human bone mar-
(C) IFN production was assayed from T cells “primed” as indicated row. Indeed, a role in NK cell development would be
following a 40 hr secondary stimulation with fresh allogeneic spleen difficult to reconcile with activated, mature T cells being
cells and no added cytokine.
the only known source of IL-21 (Parrish-Novak et al.,
2000), as the maturation of NK cells in T cell-deficient
athymic (Nassiry and Miller, 1987), RAG/ (Shinkai etlymph node T cells from wild-type or IL-21R/ (H-2b/d)
mice were activated for 3–5 days with irradiated alloge- al., 1992), and SCID (Dorshkind et al., 1985) mice argues
against any critical requirement for a T cell-derived fac-neic splenocytes (H-2k) in the presence of IL-21 or con-
trol supernatant. Similar to results with anti-CD3 stimula- tor in NK cell development. Previous studies have shown
that mice rendered deficient in IL-15 (Kennedy et al.,tion (Figure 1C), IL-21 enhanced alloantigen stimulation
of wild-type but not IL-21R/ T cells (Figure 7A). T cells 2000) and its receptor components (Di Santo et al., 1995;
Suzuki et al., 1997; Lodolce et al., 1998) or Flt3L (Mc-from both IL-21R/ and wild-type mice exhibited en-
hanced proliferation to alloantigen in the presence of Kenna et al., 2000) have profoundly reduced NK cell
numbers, underscoring the critical role of these agentsIL-2 or IL-15 (data not shown) and thus have no intrinsic
defects in responsiveness. Stimulation of T cells results in NK cell development. Other cytokines, IL-2 and ckit
ligand (SCF), play an auxiliary role. Both can synergizein the development of effector functions, including CTL
activity and IFN production. Therefore, we compared with Flt3L to drive NK cell development from bone mar-
row progenitors in vitro (Muench et al., 2000; Mrozek etthe ability of IL-21R/ and wild-type T cells to differenti-
ate into allospecific effectors in response to IL-21 and al., 1996) or when administered in vivo (Fehniger et al.,
1997), but mice lacking IL-2 (Kundig et al., 1993) or ckitrelated cytokines. For wild-type cells, IL-21 alone primed
the development of allospecific CTL activity, similar to (W/Wv mice) (Seaman and Talal, 1981; Colucci and Di
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Santo, 2000) have NK cells, albeit at reduced number interactions. An additional possibility is that the proapo-
ptotic effects of IL-21 prevail over the growth-promotingand activity. Vosshenrich and Di Santo (2001) have spec-
ulated that because IL-21R utilizes c (Asao et al., 2001) effects of IL-15, even though the pathways leading to
apoptotic versus growth signals are separate, as hasand because mice lacking c have an even more pro-
found reduction in NK cell numbers (Di Santo et al., been outlined for IL-2 effects on T cells (Van Parijs et
al., 1999).1995) than those lacking IL-15R (Lodolce et al., 1998),
IL-21 could be a key factor in promoting NK cell develop- Following an initial activation event in vivo or in vitro,
subsequent challenge with IL-21 greatly enhanced bothment in vivo. Although we cannot rule out a role in human
NK cell development, our finding of normal NK cell num- NK cell cytolytic activity per cell and IFN production.
This functional activation is necessarily transient, be-bers and full cytolytic potential in IL-21R/ mice indi-
cates that IL-21, acting through this receptor chain, is cause even as IL-21 promoted NK cell effector re-
sponses, it antagonized viability. When exposed to IL-neither essential nor regulatory for NK cell maturation
in mice. 21, activated NK cells underwent apoptosis within 2
days. Given the rapid, potent, and relatively nonspecificNevertheless, IL-21 was able to influence NK cell via-
bility and function, in a manner that discriminated be- nature of their responses, there is a clear biological
imperative to have control over expansion of NK cells.tween resting and activated cells. Although RNase pro-
tection analysis confirmed expression of IL-21R chain This normally occurs during the course of an immune
response when abatement of NK cell activation coin-transcripts in both resting and activated NK cells (data
not shown), IL-21 enhanced effector function only when cides with the emergence of antigen-specific T cells
(Biron et al., 1999). While inhibitory receptors can pre-used to restimulate NK cells following their initial activa-
tion in vivo with poly I:C, or in vitro with IL-15. In contrast, vent inappropriate activation, few agents have been de-
scribed that reduce NK cell proliferation once it hasIL-21 inhibited the IL-15-mediated expansion of NK cells
under all conditions tested. In this regard, IL-21 is dis- been initiated. The T cell-dependent release of TGF is
one such mechanism (Su et al., 1993), but clearly otherstinct from the related cytokines IL-2 and IL-15, both
of which are able to induce proliferation and cytolytic exist (Pierson et al., 1996). Recently, Loza and Perussia
(2001) have demonstrated that human NK cells undergoactivation of resting NK cells (Carson et al., 1997; Lon-
don et al., 1986). Cells from IL-21R/ mice were fully stepwise maturation from IL13-producing (NK2) to IFN-
producing (NK1) effectors, whose activation is followedable to undergo initial activation in response to poly I:C
in vivo or IL-15 in vitro but showed no enhancement of by terminal differentiation and apoptosis. Generation of
IFN-producing NK cells was stimulated by the mono-function upon restimulation with IL-21. The ability of
IL-21 to enhance effector function only of previously cyte-derived factor, IL-12, and slowed by the T cell-
derived agent, IL4 (Loza and Perussia, 2001), suggestingactivated NK cells may reflect differential expression of
alternative IL-21 receptor chains, signaling molecules, the possibility that emergence of activated T cells feeds
back to limit recruitment of NK cells into the immuneor receptor-induced transcription factors upon initial NK
cell activation. Although the basis for the differential IL- response. Our findings with IL-21, another T cell-derived
cytokine, suggest an additional mechanism whereby ac-21 responsiveness of resting versus activated NK cells
remains to be determined, the potential of IL-21 to dis- tivated T cells may influence NK cell maturation. By
blocking responsiveness of NK cells to the growth-pro-criminate between them may be important in vivo. A
recent report by Yokoyama and colleagues showed that moting effects of IL-15 while acting as a potent IFN
inducer, IL-21 may be a key regulator of NK cell func-murine NK cells responding early in the course of virus
infection are activated nonspecifically, whereas those tional status by promoting the terminal steps of NK cell
maturation.that persist late into infection require more specific acti-
vation signals (Dokun et al., 2001). The selectivity of IL- Antagonism of IL-15 function was also apparent in
IL-21 effects on CD8 T cells expressing a memory-21 for NK cells that have undergone an initial response
could be one mechanism by which those cells that per- associated phenotype, CD44hi. As described by Sprent
and colleagues, a small percentage of cells which cansist late into infection continue to receive activation sig-
nals, while the ability of IL-21 to block expansion of respond to IL-15 in the absence of TCR signaling arises
following contact with antigen in the mouse and persistsresting NK cells could be a mechanism to prevent further
recruitment of resting NK cells to the response. in vivo in the absence of ongoing antigenic stimulation
(Zhang et al., 1998). Treatment with IL-15 in vivo or inFor both resting and activated NK cells, IL-21 alone
did not sustain viability and blocked survival but not vitro selectively induces proliferation of CD44hi CD8
T cells in an antigen-nonspecific manner (Sprent andcytotoxicity induced by IL-15. The observation that
growth inhibition was absent in IL-21R/ mice argues Surh, 2001). Although cells with this phenotype initially
arise primarily following encounter with antigen (Sprentthat IL-21R is required to mediate this effect. Because
IL-21 blocked NK cell growth in response to IL-2 as well and Surh, 2001), their subsequent TCR-independent,
cytokine-mediated reactivation displays functionalas IL-15 (data not shown) and all three cytokines utilize
the c receptor chain (Asao et al., 2001), one possible characteristics allied with the innate immune response.
They undergo bystander proliferation in vivo in responseexplanation is that IL-21 blocked growth effects by com-
peting for a limited pool of c receptor chains. This type to type I interferon or poly I:C (Tough et al., 1996), expand
within the first 2 days of virus infection (Turner et al.,of inhibition should be overcome by addition of higher
amounts of IL-15. In our experiments, however, IL-21 2001), proliferate in response to LPS administration
(Tough et al., 1997), and produce IFN in vivo withinblocked NK cell outgrowth at all doses of IL-15 to which
the NK cells responded, inconsistent with a model of hours of bacterial infection (Lertmemongkolchai et al.,
2001). In our studies, addition of IL-21 inhibited the IL-simple competition between IL-21 and IL-15 for c chain
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Experimental Procedures15-mediated in vitro expansion of CD44hi CD8 T cells
from wild-type but not IL-21R/ spleen. It has yet to
Targeting the IL-21R Gene by Homologous Recombinationbe determined whether this decreased expansion is due
and Generation of IL-21R/ Mice
to prevention of IL-15-induced proliferation or is a pro- A 400 bp Sph1/EcoRV cDNA fragment of IL-21R corresponding to
apoptotic effect of IL-21 similar to that of IL-2, which 5
 coding regions (aa 2–135) was used as a probe to screen a
Stratagene (La Jolla, CA) C57BL/6 mouse liver genomic library formay override the growth signals of IL-15 to induce apo-
the IL-21R gene. Four clones were isolated from screening 1  106ptosis in T cells (Li et al., 2001), including CD44hi CD8
colony forming units. One clone of approximately 13 kb was paritallyT cells (Ku et al., 2000). Decreased IL-15 responsiveness
sequenced and found to contain two exons corresponding to theof CD44hi CD8 T cells mediated by the T cell activation
signal sequence region of murine IL-21R. The first leader exon
product, IL-21 (Parrish-Novak et al., 2000), may be one (MPRGPVAALLLLILHG) was targeted for deletion by replacing it
mechanism whereby cytokine-driven “bystander” T cell with a neomycin resistance cassette (Figure 1A). A 3.8 kb Avr2
fragment 5
 to the first leader exon and a 2.0 kb Sac1/Hind3 intronicproliferation is reduced once specific immunity
fragment 3
 to the first leader exon were ligated, 5
 and 3
, respec-emerges. A recent report that CD44hi CD8 T cells un-
tively, via linkers (Avr2/Xho1 and BamH1/Sac1) to the 1.1 kb Xho/dergo apoptosis-mediated attrition upon induction of
Bam neomycin cassette and subcloned into pTK(SK).TCR-mediated anti-viral immunity in LCMV infection
IL-21R/ mice were generated by targeting the IL-21R gene in
(McNally et al., 2001) is consistent with this hypothesis the J12 embryonic stem cell line (C57BL/6 origin), injecting clones
and suggests a role for IL-21. into blastocysts, and transferring to pseudopregnant B6CBA F1
females. Resulting male chimeras were bred to BALB/c females, andWhereas IL-21 failed to support expansion of either
offspring were analyzed by PCR and Southern blotting for germlineNK cells or cytokine-activated, TCR-independent CD44hi
transmission of the mutant alleles. Mice heterozygous for the IL-CD8 T cells, it delivered a potent TCR-dependent ac-
21R mutation (IL-21R/) were intercrossed to yield homozygouscessory signal for T cell responses to alloantigen. Both
offspring (IL-21R/) on the BALB/c  C57BL/6 background and
the allospecific proliferation of freshly isolated T cells subsequently bred onto the C57BL/6 background. The lack of IL-
and secondary effector responses, including cytotoxic- 21R expression in IL-21R/ mice was confirmed by PCR analysis
using total RNA isolated from tail bleeds and analysis of amplifiedity and IFN production, were stimulated by IL-21. Po-
products by Southern blot. Mice on the BALB/c  C57BL/6 back-tentiation of TCR-mediated responses was also appar-
ground were used for initial characterization and those on theent in the enhanced proliferation of both thymic and
C57BL/6 background were used for functional studies, unless other-peripheral T cells in response to suboptimal concentra-
wise noted. Data are presented for mice aged between 8–12 weeks.
tions of anti-CD3 with IL-21. To underscore the essential
role of IL-21 in these costimulatory responses, cells from Murine IL-21
IL-21R/ mice were used in an allogeneic MLR and did The 441 bp coding region of mIL-21 cDNA encoding a protein of
146 amino acids (Parrish-Novak et al., 2000) was inserted into thenot display IL-21-mediated potentiation of allogeneic
COS-1 expression vector, pEDc. COS transfectants were grownT cell responses. While this might indicate that IL-21R/
in DMEM containing 10% FBS in 10% CO2. Cells were placed incells are somehow impaired in antigen specificity or in
serum-free DMEM for 30 hr post-transfection and IL-21 containinginteraction with APCs, the finding that these cells had
supernatant was collected 24 and 48 hr later. The supernatant was
full lytic capacity against allogeneic targets confirms concentrated 50 by Amicon filtration. PMSF and EDTA were added
their antigen-recognition potential. These observations to prevent proteolysis. One unit of activity was defined as the
concentration of supernatant required to induce 50% maximal prolif-implicate IL-21 as a potent inducer of CD8 effector
eration of Ba/F3 cells transfected with IL-21R. When tested in themechanisms in response to allogeneic stimulation and
absence of exogenous IL-3, proliferation of these tranfectants is IL-suggest that in the presence of IL-21, the expansion
21 dependent. Mock-transfected COS supernatant prepared andand effector mechanisms of antigen-specific T cells
concentrated in parallel with IL-21 was used as a control.
would be greatly enhanced, even as NK and antigen-
nonspecific T cell responses were diminished. NK Cell Activation In Vitro
In summary, these studies show that IL-21R is not Spleen cell suspensions were depleted of RBC with ammonium
chloride and plated in RPMI containing 10% FBS, 50 U/ml penicillin,required for the development of NK cells in the mouse,
50 g/ml streptomycin, 2 mM L-glutamine, and 50 g/mlbut is necessary to mediate all NK cell and T cell re-
-mercaptoethanol with 10–50 ng/ml recombinant human IL-15sponses to IL-21 that were examined. IL-21 reduced
(R&D Systems, Minneapolis, MN), 12.5 U/ml recombinant mouse IL-survival of both resting and activated NK cells, even
21, or an equal volume of COS mock control supernatant. This dose
while promoting the effector function of those NK cells of IL-21 had been shown to have maximal activity for the inhibition
that had undergone initial activation in vivo or in vitro. of NK cell outgrowth (data not shown). Cells were cultured at 5%
CO2 for 7 days, with a second dose of IL-15 and IL-21 or COS mockIL-21 also inhibited the proliferation of TCR-independent
control added on day 4. On day 7, nonadherent and adherent cellsCD44hi CD8 T cells in response to IL-15. In contrast,
were assayed for cytotoxicity, IFN production, or cell surface phe-it provided a potent accessory signal for anti-CD3 or
notype.
antigen-dependent T cell proliferation and effector func-
tion. During the course of an immune response, the NK Cell Activation In Vivo
development and mobilization of antigen-specific T cells Mice were injected i.p. with 0.15 ml PBS containing 1 mg/ml poly-
coincides with diminished innate responses. This transi- inosinic-polycytidylic acid (poly I:C; Sigma) or PBS control. Spleens
were harvested 1.5 days later, and cells were used in a 51-Cr releasetion, which involves a decrease in NK cell numbers and
assay against YAC-1 targets.concomitant T cell expansion (Biron et al., 1999), may
be initiated by the presence of activated, mature T cells.
NK CytotoxicityAs a product of activated T cells that functions to aug-
YAC-1 target cells (American Type Culture Collection, Manassas,
ment antigen-specific T cell responses while antagoniz- VA) were incubated for 1 hr with sodium 51-chromate (20 Ci/1 
ing NK cell survival, IL-21 may be a key facilitator of this 105 cells; New England Nuclear, Boston, MA), washed, and plated
with effector cells at the indicated effector:target cell (E:T) ratio.transition.
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